ArticleAmerican journal of hematology2021

Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality.

Abhishek Maiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.